The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Clinical trial NCT03665480 · UNKNOWN

Trial details

NCT number: NCT03665480
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Granulocyte Colony-stimulating Factor Minimal Residual Disease Acute Myeloid Leukemia

Start date: 2018-09-04
Primary completion: 2020-08-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.